News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TeGenero AG's TGN 1412 Phase 1 Trial Goes Wrong In UK, Two Critically Ill


3/15/2006 10:32:33 AM

LONDON, March 15 (Reuters) - Two men were critically ill in a British hospital on Wednesday and four others serious in intensive care after suffering violent reactions to TeGenero AG's new drug (TGN 1412) they took as part of a clinical trial conducted by Parexel International Corp. Police said they were working with the country's medicines watchdog to establish the circumstances.

Read at Reuters
Read at CNN
Read at Bloomberg
Read at The Age
Read at Deccan Herald
Read at BBC News
Read at Independent
Read at New Scientist

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES